Here's the live share price of Viyash Scientific along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Viyash Scientific | 1.75 | -9.60 | -15.27 | 12.82 | 9.24 | 35.87 | 1.57 |
| Sun Pharmaceutical Industries | -2.81 | -5.63 | -9.10 | 6.31 | 5.28 | 16.03 | 16.14 |
| Divi's Laboratories | 0.91 | -0.28 | 37.21 | 53.26 | 44.78 | 36.18 | 12.76 |
| Torrent Pharmaceuticals | -1.74 | -5.06 | -4.58 | 12.55 | 32.28 | 35.83 | 24.18 |
| Zydus Lifesciences | -0.55 | 1.88 | -1.00 | 24.42 | 14.65 | 23.85 | 15.76 |
| Laurus Labs | 4.12 | 6.97 | 34.63 | 88.63 | 136.19 | 72.98 | 26.49 |
| Cipla | -2.46 | -4.80 | -8.69 | 6.84 | -15.87 | 4.38 | 7.54 |
| Dr. Reddy's Laboratories | 2.53 | 7.86 | -1.20 | -0.12 | -2.71 | 3.95 | 4.69 |
| Mankind Pharma | -5.07 | 6.81 | -4.98 | 15.41 | -2.43 | 10.66 | 10.99 |
| Aurobindo Pharma | 1.66 | 2.02 | 8.83 | 26.13 | 50.61 | 23.64 | 18.77 |
| Lupin | -4.09 | -6.22 | -22.04 | -16.58 | -0.70 | 18.99 | 15.20 |
| Glenmark Pharmaceuticals | -2.32 | -5.59 | -0.01 | 5.51 | 17.67 | 42.66 | 33.72 |
| Alkem Laboratories | -0.29 | 2.25 | -7.84 | -3.95 | -4.18 | 13.47 | 5.88 |
| Biocon | -6.92 | -11.47 | -17.49 | -0.96 | -2.17 | 10.23 | -0.84 |
| Abbott India | -3.79 | 2.15 | -4.83 | 0.18 | -14.45 | 4.31 | 3.22 |
| Gland Pharma | 6.94 | 4.23 | 23.93 | 76.62 | 59.90 | 23.66 | -4.21 |
| Anthem Biosciences | 3.40 | -6.22 | 17.00 | 18.57 | 10.37 | 6.54 | 3.87 |
| Ipca Laboratories | -2.29 | -3.76 | 6.07 | 30.21 | 42.11 | 25.80 | 9.98 |
| GlaxoSmithKline Pharmaceuticals | -9.03 | -11.15 | 3.63 | 5.46 | -8.69 | 17.96 | 11.31 |
| Ajanta Pharma | -4.99 | -3.22 | 1.56 | 21.41 | 39.81 | 24.25 | 17.26 |
Source: Dion Global
Over the last one year, Viyash Scientific has gained 9.24% compared to peers like Sun Pharmaceutical Industries (5.28%), Divi's Laboratories (44.78%), Torrent Pharmaceuticals (32.28%). From a 5 year perspective, Viyash Scientific has underperformed peers relative to Sun Pharmaceutical Industries (16.14%) and Divi's Laboratories (12.76%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 234.29 | 235.71 |
| 10 | 237.66 | 237.81 |
| 20 | 244.72 | 243 |
| 50 | 256.57 | 251.07 |
| 100 | 259.09 | 249.4 |
| 200 | 232.58 | 236.92 |
Source: Dion Global
In the latest quarter, Viyash Scientific remained same as its previous close in promoter holding, while DII stake decreased to 3.76%, FII holding rose to 4.50%, and public shareholding moved up to 30.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 36,05,508 | 1.31 | 95.04 | |
| 35,17,910 | 1.45 | 92.73 | |
| 28,75,000 | 0.36 | 75.79 | |
| 20,82,301 | 1.76 | 54.89 | |
| 19,76,797 | 0.95 | 52.11 | |
| 11,43,827 | 0.17 | 30.15 | |
| 8,41,690 | 1.54 | 22.19 | |
| 5,40,000 | 0.55 | 14.23 | |
| 2,15,674 | 0.25 | 5.69 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 08, 2026, 04:27 PM IST IST | Viyash Scientific - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Oct 06, 2026, 08:34 PM IST IST | Viyash Scientific - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2026, 11:17 PM IST IST | Viyash Scientific - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| Sep 18, 2026, 05:56 AM IST IST | Viyash Scientific - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Sep 09, 2026, 12:12 AM IST IST | Viyash Scientific - Update On Proposed Acquisition Of Bioforlife Italia S.R.L |
Source: Dion Global
Viyash Scientific Ltd. is a Public Limited Listed company incorporated on 28/06/1985 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1985PLC036685 and registration number is 036685. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 1382.06 Cr. and Equity Capital is Rs. 87.37 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Viyash Scientific is ₹235.85 as on Oct 12, 2026.
The Viyash Scientific is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Viyash Scientific is ₹10,418.99 Cr as on Oct 12, 2026.
Today’s highest and lowest price of Viyash Scientific are ₹241.95 and ₹235.00.
The 52-week high/low is the highest and lowest price at which Viyash Scientific stock has traded in the past 52-week or nearly a year. The 52-week high of Viyash Scientific is ₹297.90 and 52-week low of Viyash Scientific is ₹178.40 as on Oct 12, 2026.
The Viyash Scientific has shown returns of 0.64% over the past day, -9.6% for the past month, -15.27% over 3 months, 9.24% over 1 year, 35.87% across 3 years, and 1.57% over 5 years.
P/E ratio of and PB ratio of Viyash Scientific are 60.87 and 3.48 on Oct 12, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global